Reason: Non-Sterility: FDA analysis found unopened tubes to be contaminated with bacteria.
Distributed: Product was imported by one distributor, Delsam Pharma, LLC, who further distributed the product via internet sales Nationwide in the USA.Reason: Failed Content Uniformity Specifications
Distributed: USA nationwide.Reason: Defective Delivery System: Out of specification for shear.
Distributed: US NationwideReason: Defective Delivery System: Out of specification for shear.
Distributed: US NationwideReason: Defective Delivery System: Out of specification for shear.
Distributed: US NationwideReason: Defective Delivery System: Out of specification for shear.
Distributed: US NationwideReason: Labeling: Label Mix-up
Distributed: Product was distributed nationwide within the United States and PRReason: Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
Distributed: Nationwide in the U.S.A.Reason: Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.
Distributed: AZ, OH, MS.Reason: Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Distributed: Nationwide